News

Business Wire3d
KalVista Pharmaceuticals Announces FDA Approval of EKTERLY® (sebetralstat), First and Only Oral On-demand Treatment for Hereditary Angioedema
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the U.S. Food and Drug Administration (FDA) has approved EKTERLY® (sebetralstat), a novel ...
'They were frustrated with the system': Local elderly couple struggle to get REAL ID for urgent travel
It's very difficult to get a DMV appointment to stay compliant and get an enhanced or REAL ID, and some people in the ...
Pharmaceutical Technology on MSN2d
FDA approves KalVista’s Ekterly for hereditary angioedema
The US Food and Drug Administration (FDA) has approved KalVista Pharmaceuticals' Ekterly (sebetralstat) as the first and only ...
Managed Healthcare Executive2d
FDA Approves Ekterly, First Oral Treatment for Hereditary Angioedema
Ekterly comes in the form of a 300 mg tablet. The recommended dosage is 600 mg split into two doses taken at the earliest sign of an attack, according to the prescribing information. Additional ...
Elderly people with dementia being subjected to violence, abuse and neglect in their own homes
There's a clear downside to the Norwegian policy that encourages allowing elderly people to live at home for as long as ...
Moulton woman accused of exploiting, neglecting elderly couple
Sarah Queen of Moulton faces charges of financial exploitation of the elderly in the first degree and elder neglect in the ...